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Abstract
Helicobacter pylori induces cytokine mediated changes in gastroduodenal pathophysiology, wherein, the activated
macrophages at the sub-mucosal space play a central role in mounting innate immune response against the antigens. The
bacterium gains niche through persistent inflammation and local immune-suppression causing peptic ulcer disease or
chronic gastritis; the latter being a significant risk factor for the development of gastric adenocarcinoma. What favors
persistence of H. pylori in the gastric niches is not clearly understood. We report detailed characterization of a functionally
unknown gene (HP986), which was detected in patient isolates associated with peptic ulcer and gastric carcinoma.
Expression and purification of recombinant HP986 (rHP986) revealed a novel, ,29 kDa protein in biologically active form
which associates with significant levels of humoral immune responses in diseased individuals (p,0.001). Also, it induced
significant levels of TNF-a and Interleukin-8 in cultured human macrophages concurrent to the translocation of nuclear
transcription factor-kB (NF-kB). Further, the rHP986 induced apoptosis of cultured macrophages through a Fas mediated
pathway. Dissection of the underlying signaling mechanism revealed that rHP986 induces both TNFR1 and Fas expression to
lead to apoptosis. We further demonstrated interaction of HP986 with TNFR1 through computational and experimental
approaches. Independent proinflammatory and apoptotic responses triggered by rHP986 as shown in this study point to its
role, possibly as a survival strategy to gain niche through inflammation and to counter the activated macrophages to avoid
clearance.
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Introduction
Infection of human gastric mucosa with H. pylori is associated
with different forms of gastro-duodenal diseases such as gastritis,
peptic ulcers and gastric adenocarcinoma [1]. However, despite
the fact that it colonizes more than 50% of the population
worldwide, only a small subset of those infected develop more
severe forms of gastric diseases; this may be due to various
environmental and pathogen specific factors apart from different
host immune responses [2,3].
Establishment of successful colonization is a complex process
that involves activities of several genome encoded virulence
factors, aimed perhaps at survival through inflammation and
defense via suppressing innate immune responses.
Once established in the host, H. pylori triggers activation of
transcription factors and secretion of mucosal proinflammatory
cytokines followed by cytoskeletal rearrangement, enhanced cell
proliferation and apoptosis [4]. The induction of proinflammatory
cytokines (IL-8 and IL-6) by H. pylori is mediated through NF-kB
via recognition of toll-like receptors (TLRs) [5,6]. Translocation of
NF-kB by H. pylori promotes either the inflammatory process
through induction of proinflammatory cytokines or regulates host
defense by promoting or inhibiting apoptosis [7]. There are
experimental evidences supporting the pro- and anti- apoptotic
roles of NF-kB; its role in TNF-alpha /FasL mediated apoptosis
has been described [8].
Given the proinflammatory responses aimed basically at gaining
niche, the bacterium also appears to have evolved mechanisms to
avenge primary defense maintained by the activated macrophages
and lymphocytes [9]. This may involve selective inhibition of T-
cell proliferation through up-regulation of Fas antigen [10], which
is possibly mediated by cytokines (TNF-a and IL-1b), reactive
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oxygen metabolites and iNOS [11, 12, and 13]. This may reveal
that although the persistent infection substantially increases
mucosal inflammation, loss of activated macrophages proportion-
ately limits clearance from the host [14,15] leading to chronicity of
inflammation.
H. pylori encodes several virulence associated molecules,
including proapoptotic (such as VacA) [16] and anti apoptotic
(such as CagA) [17] effectors and toxins, besides important
virulence factors such as OipA, Ure, flagellins and adhesins.
Although the functional coordinates of these factors have been
extensively determined in different studies [18,19], discrete
associations of these with different disease outcomes have
contradicting evidences [20]. In particular, microevolution and
allelic diversity of the cagPAI, and vacA do not allow robust
genotype-phenotype correlations thereby posing an obvious
difficulty in linking the evolving virulence factors with the
pathology [21]. In view of this, it is possible that the bacterium
harnesses alternative strain specific factors [22] to achieve
persistent infection. Also, there are several hypothetical and
unknown proteins coded by H. pylori genome whose functional role
in pathogenesis is unexplored. Therefore, it is pertinent to look
into the biology of novel genes/proteins to get new insights into
pathogenesis and phenotypic diversification of the bacterium in a
changing host. The cache of many strain specific genes (the
putative virulence factors) [23] comprises the ‘plasticity zone’ of H.
pylori chromosome. Functional characterization of such genes and
their involvement in pathogenesis of H. pylori could facilitate clear
understanding of the development of peptic ulcer disease and
gastric carcinoma. In this study, we describe efforts to systemat-
ically decipher the proinflammatory and apoptotic roles of one
such putative virulence factor, HP986, and how this observation
reinforces our understanding of the biology of H. pylori
colonization and persistence.
Results
Association of HP986 with invasive disease outcomes
and its distribution in clinical isolates
HP986 was found to be present in more than 61% of the total
isolates we screened from many different geographical regions
(Figure1 A, C). Overall, the presence of this gene was significantly
associated with invasive disease (peptic ulcer and gastric
carcinoma, 72%) outcomes (Figure 1B). This apparently contrasts
previous observations [24] that describe HP986 to be gastritis
specific. Also, the gene was found consistently conserved in all the
three strains isolated from different niches of the stomach, almost a
decade-apart [25], from a single patient (Figure 1 A). This suggests
that despite a genome wide trend of extensive rearrangements in
H. pylori, HP986 remains conserved.
Protein sequence analysis and structure function
prediction
HP986 was predicted to be H. pylori specific with no obvious
sequence similarity in the available microbial sequence databases.
Functional prediction showed high antigenic indices equivalent to
,3.4 (DNAstar software, DNAStar Inc, USA). Due to the
unavailability of crystallographic/solution structure of HP986, a
search for possible homologs was carried out using several
programs. Sequence-based search methods (BLASTp) did not
provide any significant hit but sequence searches in PDB identified
a template with 22% identity. This template (PDB ID: 1XMX)
was a hypothetical protein, VC1899 from V. cholerae and a
structural model of HP986 was built using it (Figure 2A). Total 50
solutions were obtained using Modeller9v8 [26] and solution
No. 33 was considered the best among them on account of less
energy. The quality of the structure was assessed using
Ramachandran plot obtained via Procheck , which displayed
88.6% residues in most favored regions and 0.9% residues in
disallowed regions. Consequently, ModLoop [27] was used to re-
build the two residues in the modelled region followed by energy
minimization. Results of the model validation using Procheck
program were as follows: 89.0% residues in the most favored
regions; 10.0% residues in the additional allowed regions; 0.9%
residues in the generously allowed regions and 0.0% residues in
the disallowed regions. Secondary structure analysis showed ten
alpha helices and seven beta sheets in the modelled structure
(Figure 2B). HEX [28], GRAMM-X [29] and PatchDock [30]
programs were employed for unbound protein-protein docking
with TNFR1 as receptor and HP986 as a ligand. Approximately
1000 predictions were generated using PatchDock and were
submitted to FireDock [31] to refine 10 best solutions on the basis
of global energy. Possible binding interface residues were identified
using 3D2GO binding site prediction server [32]. Several of the
lowest energy docking models emerging from this exercise placed
the HP0986 on the side of the TNFR1. Among ten docked
complexes, complexes 1 and 4 were identified as the plausible ones
on the basis of minimum energy score and binding interface
residues. A docking model of TNFR1-HP0986 is shown in
Figure 2C, in which loop 1 and 2 regions of TNFR1 are docked
onto a helices of HP0986.
Expression and purification of rHP986
The over-expressed rHP986 was purified to homogeneity under
native conditions as a His-tagged protein in E. coli BL21 (DE3).
Homogeneity of the protein was further confirmed by fast
performance liquid chromatography (FPLC). The purified protein
upon fractionation on a 10% polyacrylamide gel showed a single
band corresponding to ,29 kDa on staining with Coomasie
brilliant blue dye.
Humoral responses to rHP986
A strong and significant humoral response (p,0.0001) was
observed in H. pylori infected diseased subjects as compared to H.
pylori negative individuals (Figure 1 D). Mean value of serum
antibody levels (Mean 6 SD) in H. pylori infected patients was
0.39760.081 (Mean 6 SD) as compared to H. pylori negative
subjects 0.13360051). However, rHP986 did not show disease
stage wise (gastritis, peptic ulcer and gastric carcinoma) serum
reactivity.
rHP986 induces proinflammatory cytokines (TNF-a and
IL-8) in a dose and time dependent manner
rHP986 elicited strong cytokine response both in cultured /
PMA differentiated Thp1 cells (Figure 3 A, C) and in human
polymorphonuclear blood monocytes (PBMC) in a dose depen-
dent manner (Figure 3 E, G). A significant increase in induction
of TNF-a (p,0.0016) and IL-8 (p,0.0003) as compared to
untreated cells was observed. Time kinetics revealed active
production of TNF-a (P,0.0003) within 6 hrs of stimulation
(Figure 3 D, H) which decreased slowly after 12 hours. In contrast,
IL-8 secretion increased during this period with peak response
noted at 12 hours post stimulation; levels were more or less
maintained up to 48 hours (Figure 3 B, F). An unrelated His-
tagged recombinant protein, isocitrate dehydrogenase (ICD) from
H. pylori failed to demonstrate cytokine response even at the
highest concentration of 10 mg/ml (data not shown). Further,
inductions of these proinflammatory cytokines by rHP986 were
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not affected when the protein was treated with polymixin B.
Additionally, proteinase-K treatment confirmed loss of rHP986
induced cytokine responses suggesting that the effect was due to
rHP986 (Figure 3 A, C).
rHP986 induces IL-8 through NF-kB
The role of transcription factor NF-kB in regulating the
expression of IL-8 is already well established [33]. We observed
a significant and proportionate increase in the activation of NF-kB
complex in rHP986 treated cells in a dose (Figure 3 I) and time
dependent manner (Figure 3 J) as compared to untreated cells and
cells treated with LPS (Figure 3 I,J). Recombinant ICD from H.
pylori was used as an unrelated control (Figure 3 J) and the levels of
NF-kB complex corresponding to ICD were similar to those
observed with untreated cells. Competition with unlabeled NF-kB
DNA probe confirmed the specificity of the complex. Further,
exclusive involvement of rHP986 in the activation of NF-kB
complex was confirmed by using antibodies specific to p65, p50
and c-Rel. Addition of antibodies led to the supershift of p65 and
p50 subunits in the extract of cells treated with rHP986 or LPS
(Figure 3 K). No binding to anti- c-Rel antibody was observed
(Figure 3 K). Actin was used as an equal loading control (Figure 3
Figure 1. The locus hp986 was found to be associated with chronic gastric disease conditions. Panel A - Hp986 is widely distributed in
different geographical regions; Panels B and C - Bar diagrams to represent % prevalence of hp986 in different disease categories and in different
geographic regions, respectively; Panel D - Humoral responses directed against rHP986 were analyzed in sera collected from H. pylori infected
patients belonging to different diseased categories and from control individuals (healthy controls and H. pylori non infected subjects). Antibody titers
against rHP986 were compared between infected subjects and control individuals (P,0.001).
doi:10.1371/journal.pone.0022530.g001
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K). It was thus confirmed that rHP986 up regulates NF-kB, which
in turn induces IL-8 expression.
HP986 functions through interaction with TNFR1
rHP986 triggered the expression of TNFR1 by the Thp-1
differentiated macrophages (Figure 4 A). We also tested the
possible interaction of rHP986 with TLR4 and TLR2; however,
rHP986 treatment did not have any effect on toll-like receptor
expression (Figure 4 B, C). This finding was further confirmed by
analyzing the antagonist effect of TNFR1 receptor on NF-kB
translocation. Pretreatment of cells with neutralizing antibodies
against TLR4 and TLR2 did not abrogate NF-kB translocation
(Figure 4 D), however, this did happen when cells were pretreated
with a neutralizing antibody against TNFR1, suggesting the
possible role of rHP986 in increased TNFR1 expression (Figure 4
D).
Interaction of rHP986 with TNFR1 was further validated by
immunoprecipitation using anti-TNFR1 antibodies. The receptor
was detected in the eluate treated with rHP986 but could not
detect any corresponding signals in the cell lysate treated with
either LPS or recombinant ICD (Figure 4 E). Exclusive interaction
of rHP986 with TNFR1 was further confirmed in competition
with neutralizing antibodies against TNF a; the amount of
immune complex detected was less as compared to that seen in the
absence of TNF-a (Figure 4 F). This suggested a direct interaction
between TNFR1 and rHP986 and ruled out any possible role of
endogenous TNF-a. Further, BIAcoreH (Surface Plasmon Reso-
nance) (GE Healthcare Ltd.) analysis provided insights into the
interaction of rHP986 and TNFR1 interaction. Using 1:1
Langmuir binding model to fit our binding curve, we found that
rHP986 indeed binds with TNFR1 (ka=1.26610
465.626
102 Ms21) on the biosensor surface. The resultant complex was
found to be highly stable as illustrated by slow dissociation rate
(kd=9.08610
2463.8061025 s21). A good binding fit (x2= 8.94)
was obtained confirming the above values of ka and kd (Figure 4 G).
rHP986 induces Fas mediated apoptosis
Considering the interaction of rHP986 with TNFR1, its possible
involvement in inducing Fas expression was tested as the latter is
known to function in synergy with TNFR1 and constitutively
regulates downstream signaling cascade leading to apoptosis [11].
Pretreatment of PMA differentiated cells with rHP986 effectively
Figure 2. Sequence alignment and predicted3D-structure of HP986. Panel A - Sequence alignment of HP986 with the hypothetical protein
(VC1899) from Vibrio cholerae (PDB code 1XMX). Strictly conserved residues are highlighted in red and partially conserved residues are yellow. The
sequence numbering refers to HP986. Final B - Predicted 3D-structure of HP986. The protein secondary structures elements are labelled and colored.
Panel C - Interaction of HP0986 with TNFR1 using PatchDock and FireDock. The residues of HP986 and TNFR1 are colored in cyan and green
respectively. The residues showing interaction between both proteins are labelled and displayed as stick model in element colors (carbon colored
green/pink, nitrogen colored blue, and oxygen colored red). Hydrogen bonds are represented by black dashed lines.
doi:10.1371/journal.pone.0022530.g002
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regulated Fas expression in a time and dose dependent manner.
Comparative expression analysis with increasing protein concen-
tration at different time points revealed significant and propor-
tionate increase in Fas expression up to 24 hours (Figure 5 A).
Expression levels declined after 12 hrs in cells subjected to higher
protein dose (5.0 mg/ml). This could be due to possible increased
cell death. Immunocytochemical staining also showed an
increased expression of Fas on the surface of rHP986 stimulated
cells as compared to unstimulated ones (Figure 5 B).
Corroborating our findings with an earlier study [13] on the
synergistic function of TNFR1 and Fas in inducing apoptosis, we
evaluated the potential of rHP986 as an apoptosis-inducing agent.
rHP986 triggered apoptosis in cultured macrophage cells in a dose
and time dependent fashion (Figure 5 C). Furthermore, apoptosis
as a function of Fas expression was also mechanistically shown
through binding with annexin-V and acridine orange (Figure 5 D).
A substantial and proportionate increase in cell death was
observed when the cells were treated with increasing concentration
of rHP986 (0.5 mg/ml-10 mg/ml) for varied time intervals; up to
48 hours (36.65%63.25% to 41.0%64.2%) as compared to
untreated cells (10.65%61.85%). This pro-apoptotic property of
rHP986 declined significantly upon blocking its interaction with
TNFR1 (Figure 5 E) indicating the involvement of rHP986 in
TNFR1mediated cell death. Similar results were obtained when
the cells were stimulated in the presence of neutralizing antibody
against TNF-a, suggesting that the effect was not secondary to
endogenous TNF-a. As expected, His-tagged ICD protein from H.
pylori failed to induce apoptosis. A comparative analysis between
oleandrin (a known inducer of apoptosis) [34] and rHP986 also
confirmed the latter being an equally potent inducer of apoptosis
Figure 3. rHP986 stimulates the production of proinflammatory cytokines (IL-8 and TNF-a) through NF-kB. Panels A and B - Bar
diagram and graph representing the amount of IL-8 secreted in Thp1-cells followed by exposure to rHP986; Panels C and D - The dose and time
kinetics of TNF-a induction by rHP986 treated cells. Panels E and F - Dose and time dependent secretion of IL-8 by human PBMCs following rHP986
stimulation; Panels G and H – Dose and time dependent effect on the levels of TNF-a in human PBMC treated with rHP986. Results are shown as
mean6 SE and represent findings from one of the three independent experiments. Panel I - Dose dependent effect of rHP986 on the translocation of
NF-kB complex; lane1 - unstimulated cells, lane2 - cells treated with LPS, lanes 3 to 7 - cells treated with 0.5 mg/ml, 1.0 mg/ml, 2.5 mg/ml, 5.0 mg/ml
and 10 mg/ml concentrations of rHP986 protein, respectively. Panel J - rHP986 mediated translocation of NF-kB complex was analyzed by
electrophoretic mobility shift assay (EMSA); lane 1 – free probe, lane 2 – cold competition, lanes 3 and 4 – controls (LPS and ICD, respectively), lane 5 –
negative control (cells without rHP986 treatment). Cells were treated with rHP986 (0.5 mg/ml) for varied time periods, lane6 - 6 hrs, lane7–12 hrs and
lane8–24 hrs. Panel K - Supershift assay (K); specificity of rHP986 mediated activation of NF-kB complex was detected using specific antibodies
against p65, p50 and c-Rel. Nuclear extracts prepared from differentiated cells treated with either rHP986 (lane5-p65, lane6-p50 and lane7-c-Rel) or
LPS (lane1-p65, lane2-p50 and lane3-c-Rel) were incubated with antibodies as described in materials and methods. Nuclear extract from rHP986
treated cells incubated with b-actin was used as control - lane4.
doi:10.1371/journal.pone.0022530.g003
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(Figure 5 E). Collectively, all these findings confirm rHP986 to be
a potent apoptosis-inducing agent.
Discussion
Novel genes constantly emerge from newly sequenced replicate
genomes. This paradigm was supported by the analyses wherein
the pan-genome of a true bacterial species remained ‘open’ and
each new genome sequence would identify dozens of new genes in
the existing pan-genome of Streptococcus agalactiae, for example [35].
It is clear also from previous studies that a pool of strain specific
genes in pathogens such as H. pylori termed the ‘plasticity region
cluster’, could be useful in adaptation to a particular host
population [36]. This pathogen shows a very strong geographic
adaptation and is known for harboring up to 45% strain specific
genes with most of them gained through horizontal gene transfers
[36]. Recently, the members of the plasticity region cluster were
shown to be likely involved in promoting proinflammatory
potentials of some of the strains, possibly providing a survival
advantage [37,38].
However, a majority of the plasticity region genes /proteins are
yet to be fully characterized. We recently reported functional
characterization of JHP940, a novel antigen from this region that
has shown potential proinflammatory activity [37]. However, it is
not clear if plasticity region proteins provide any survival
advantage to the pathogen and the mechanisms thereof. The
present study attempted to explore functional aspects of HP986 as
a putative virulence factor and to examine its prevalence in clinical
isolates from different geographical regions. Also, we performed a
series of activity experiments to elucidate its role in pathology; in
particular, its proinflammatory and apoptotic activity in human
macrophages. We used differentiated human macrophages since
Figure 4. Interaction of HP986 with TNFR1 analyzed by flow-cytometry and immunoprecipitation. Panel A - Enhanced expression of
TNFR1 following treatment with rHP986; Panel B - HP986 did not stimulate expression of TLR2 - levels were equal to the cells that had not received
any protein treatment; Panel C - Treatment of HP986 had no visible effect on TLR4 expression [in the inset, lane 1 - untreated cells, lane 2 - cells
treated with HP986 and lane 3 - cells treated with rHsp60 (from M. tuberculosis) used as control; Panel D - EMSA showing effects of neutralizing
antibodies against TNFR1, TLR2 and TLR4 on the translocation of NF-kB complex in the cells stimulated with HP986 [lane1- free probe, lane2 –
unstimulated/untreated cells, lane 3- cells treated with LPS, lane4 – cells treated with ICD, lane5- cells treated with JHP940, lane6 - cells treated with
HP986, lane7- cells treated with HP986 and neutralizing antibody against TLR4, lane8 - cells treated with HP986 and neutralizing antibody against
TLR2, lane9 - cells treated with rHP986 and neutralizing antibody against TNFR1 and lane 10 - specific competitor (unlabelled NF- kB consensus
probe)]; Panel E -Immunoprecipitation assay showing interaction of rHP986 with TNFR1, lane 1 - input, lane 2 – cells treated and incubated with LPS,
lane3 - cells treated and incubated with ICD, lane 4 - cells treated and incubated with rHP986. Immunoblot was developed using antibodies against
TNFR1. Panel F - Role of endogenous TNF-a in binding to TNFR1 was ruled out using neutralizing antibodies against TNF-a; lane 1 - whole cell lysate
of cells, lane 2 - cells incubated with rHP986 in the presence of neutralizing antibody to TNF-a, lane 3 - cells incubated with rHP986 in the absence of
neutralizing antibody to TNF-a. Immunoprecipitate was pulled down using Talon beads as discussed in materials and methods section. Blot was
developed using anti-TNFR1 antibody. Equal protein loading was confirmed by reprobing the blot with b-actin. Panel G – Summary of kinetic
parameters for rHP986 affinity interaction with TNFR1: a= Association rate constant, b= Standard Error. c= Dissociation rate constant d=
Equilibrium association constant e = Equilibrium dissociation constant.
doi:10.1371/journal.pone.0022530.g004
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H. pylori considerably recruits and excites macrophages in the
gastric submucosa to initiate a chronic and persistent trail of
inflammatory activities leading to certain patho-physiological
changes [38,39].
In our observation, presence of HP986 gene was found to be
significantly associated with invasive disease outcomes (ulcer and
gastric cancer) as compared to gastritis (Figure 1 B); this contrasts a
previous report [24] about its prevalence in strains linked to
gastritis cases alone. In our study, low positivity was recorded in
gastritis causing strains from Peru and South Africa (Figure 1 C).
Moreover, the presence of HP986 was found to be independent of
cagA and vacA status of the strains tested by us.
Despite traditionally high allelic diversity in H. pylori, HP986
was found to be evolutionarily conserved as observed for a period
of ten years in strains isolated from different niches of the stomach
of a single patient (Figure 1A) [25]. This suggests conserved
maintenance of the locus in the genome thereby pointing to its
essential role in pathobiology of H. pylori.
Given our theoretical observations on high antigenicity of
HP986, in silico analysis showed several putative B-cell epitopes; we
experimentally tested its ability to elicit humoral and cellular
immune responses. Significant humoral immune responses
induced by HP986 may be important in diagnostic development
given the fact that many candidate antigens have suffered due to
high genetic variability across different regions and cross reactivity
with other related organisms [40]. Our analysis showed signifi-
cantly high antibody titers in H. pylori infected invasive disease
patients when compared with healthy controls or non-infected
individuals (Figure 1D). This points to the extracellular abundance
of HP986 protein and its role in stimulating immune response.
Further, since the NF-kB activation in H. pylori is often type IV
dependent, we can not rule out secretion of HP986 protein
through a type IV secretary system. Alternatively, it is possible that
the protein might be directly released into the extracellular space
in the aftermath of autolysis [41,42].
While considering the fact that H. pylori proteins released into
extracellular space may find their way into the submucosa and
augment proinflammatory signaling [39], we looked at rHP986 to
potentially augment proinflammatory cytokine secretion from
macrophages (IL-8 and TNF-a) consequent to NF-kB activation.
These presumptions are consistent with an earlier study describing
effect of H. pylori or its products on NF-kB (p65/p50) mediated
transactivation of IL-8 [6]. Interestingly, our observed stimulation
of IL-8 was found to be secondary to TNF-a secretion; maximal
concentration was detected as early as 6 hrs (Figure 3 D, H) as
compared to 12 hrs for IL-8 (Figure 3 B, F). The apparent
Figure 5. rHP986 induces Fas expression and apoptosis of cultured macrophages via a TNFR1 dependant pathway. Panel A - rHP986
induced Fas expression on the surface of differentiated macrophages as quantified by flow cytometry with anti-Fas antibody. Dose dependent
increase in Fas expression in response to treatment with increasing concentration of rHP986 (0.5 mg/ml, 2.5 mg/ml and 5.0 mg/ml) observed across
varied time intervals (12 hrs, 24 hrs and 48 hrs) is indicated by graph with pink line while the graphs with green line indicate response of cells
without protein stimulation. Panel B - Enhanced Fas expression on cell surface after stimulation with rHP986 as compared to cells without
recombinant protein stimulus. Panel C - Quantification of apoptosis in the cells treated with increasing concentration of rHP986 for varied time
intervals. Results are represented as (mean6SE) percent apoptotic cells per 300 cells. Panel D - Morphological identification of apoptotic cells by
acridine orange and ethidium bromide staining method. Arrow head indicates live cells with normal morphology (green fluorescence) and arrow
shows cells that have undergone apoptosis after stimulation with rHP986. Black arrows indicate condensed marginal nucleus, apoptotic body
formation and membrane blebbing. Panel E - Bar diagram showing inhibition of apoptosis when the cells were stimulated with rHP986 in the
presence of neutralizing antibody against TNFR1 (rHP986+TNFR1) as compared to cells stimulated with only rHP986. Oleandrin was used as positive
control; US - unstimulated cells. Results are shown as mean 6 SE.
doi:10.1371/journal.pone.0022530.g005
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decrease in TNF-a concentration may be due to the binding of
TNF-a with the soluble TNF receptors. As a consequence, less
TNF-a concentration was detected in the culture supernatant after
12 hours. Based on these findings, we propose the role of HP986
in cytokine mediated gastric injury in a similar way as shown
previously for the airway epithelial inflammation triggered by
Staphylococus protein-A [43]. The effect was consistent when tested
in both Thp1 differentiated macrophages (Figure 3 A–D) and
human PBMCs (Figure 3 E–H). It is known that H. pylori infection
disrupts tight intracellular junctions and transports its products
into the gastric submucosal space to augment infiltration of
mononuclear cells [44]. This strategy perhaps helps the bacterium
to establish persistent infection as it feeds on inflammatory
exudates for carbon source derived from mucosal sugars and
thereby gains a niche. Also, it inhibits expansion of antigen specific
T-cells as a mechanism of immune evasion [15]. Studies support
the notion that IL-8 activity attracts mononuclear cells, and TNF-
a triggers Fas mediated apoptosis of activated macrophages
[45,46]. TNF-a works in an autocrine fashion by up regulating Fas
expression on the surface of activated macrophages by binding
with TNFR1 [13] and shares a hierarchy of downstream events
(FADD) leading to apoptosis [14,47]. Nevertheless, there are
contradictory reports supporting pro and anti apoptotic roles of
Fas in different cell lineages but antigen behavior also determines
cell fate [48]. Our observed synergistic function of TNFR1 and
Fas is consistent with the previous findings [46,49]. Having
identified the dependency of Fas on TNFR1, we anticipated that
rHP986 actually binds to TNFR1 and thus mimics signalling
through TNF-a. We confirmed this interaction through a series of
immunological and biophysical measurement and our binding
results were in accordance with computational modeling of HP986
and TNFR1 interaction; Also, we could not observe any binding
with TLR4 or TLR2 (see results).
Taken together, these observations allow us to propose a model
of putative bacterial strategy (Figure 6) harnessed for survival and
possibly for maintaining a balance between recruitment and
activation of macrophages and their suppression by TNFR1
mediated apoptosis. This strategy potentially projects HP986 as an
important player involved in both proinflammatory and apoptotic
cascades. It is therefore highly probable that HP986 is a novel
virulence factor and possibly an important effecter in gastritis and
peptic ulcer disease and various other outcomes of chronic H. pylori
infection such as gastric adenocarcinoma. While we do not know
how many such virulence factors operate behinds the pathology
triggered by this manipulative pathogen, understanding of each of
them in depth is necessary to devise strategies to control
progression of the infection towards more serious outcomes.
Future efforts are indeed necessary to understand molecular
structure of this protein to gain insights into intricacies of its
function and how its role is regulated in vivo.
Materials and Methods
Ethics statement
The study was approved by the Institutional Biosafety
Committee of the University of Hyderabad, India. Informed
consents were obtained from all patients whose sera samples were
used (all patients sampled were adults).
Geographic distribution of the locus Hp986 and its
genetic stability
Distribution of hp986 gene was analyzed in clinical isolates from
different diseased subjects (gastritis n = 152, duodenal ulcers
n = 68, gastric cancer n= 27) belonging to various geographical
regions (India, Spain, South Africa, Japan, France, Peru, Ireland,
England, Costa-Rica, Indo-Tibet and Bangladesh). PCR was
performed using gene specific primers as described earlier [24].
Computational modelling of HP986 protein-protein
interactions
The 3D structure of query protein was predicted by automated
homology modelling program, Modeller9v8 [26]. The protein
template 3D structures used in the study were downloaded from
RCSB Protein Data Bank (PDB). Amino acid sequences of HP986
were aligned with PDB ID 1XMX to derive the predicted
secondary structure using the online tool, ESPript [50]. The
geometry of model was checked with PROCHECK tool available
with PDBsum program [51]. Molecular visualization and general
analysis were done using the program PyMOL [52]. In silico
docking experiments were performed using PatchDock [30] and
then further refined and ranked with FireDock [31]. In crystal
structure, the unliganded TNFR1 (PDB ID: 1NCF) exists as a
dimer, and therefore only one molecule of TNFR1 (receptor) was
taken for unbound protein-protein docking with HP986 model
(ligand) under default complex-type settings.
Cloning, expression and purification of HP986
The construct for recombinant protein expression was gener-
ated by cloning the PCR product spanning 711 bp at site XhoI/
HindIII of pRSETA. The construct was then propagated into E.coli
BL-21 (DE3) expression host and the over expressed his-tagged
protein was purified by affinity chromatography (Ni2+-NTA,
Qiagen) [53]. Further size exclusion chromatography was
performed using Superose -1210/300 GL column (GE Healthcare
Ltd.) in buffer containing 20 mM Tris-Cl and 300 mM NaCl
pH 8.0. The recombinant protein was quantified using Bradford’s
reagent [54]. Also, purified rHP986 was treated with polymixin-B
to remove possible endotoxin contamination.
Analysis for humoral responses
A total of 70 human sera were collected after obtaining
informed consents from different subjects having endoscopically
proven gastritis, peptic ulcer and gastric carcinoma. Sera from
subjects reported to be H. pylori negative (as ascertained by
C14urea breath test) were used as negative control (n = 17).
Humoral response against the rHP986 was determined by Enzyme
linked immunosorbent assay (ELISA) as described previously [53].
Concentration of recombinant protein and sera was predeter-
mined using serial dilutions to obtain optimum antibody titers
(data not shown). Each ELISA experiment was repeated at least
thrice with and without replicates.
Cell culture experiments
Approximately 16106 human monocyte cells per well (Thp1)
(ATCC, USA) were differentiation into adherent macrophage like
phenotype using phorbol-12 myristate 13 acetate at a concentra-
tion of 5 ng/ml (Sigma, USA). These cells were induced using
increasing concentration of rHP986 (0.5 mg, 1.0 mg, 2.5 mg,
5.0 mg, and 10 mg/ml) and incubated for varied time interval.
Cells without protein stimulus (unstimulated cells) and the cells
stimulated with proteinase K-treated rHP986 served as negative
control. LPS (E. coli, Sigma) treated cells were used as positive
control. A non relevant control was the His-tagged ICD from H.
pylori purified under similar conditions. Culture medium collected
at different time intervals (6 hrs, 12 hrs, 24 hrs and 48 hrs) was
stored at 280uC until assayed.
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Polymorphonuclear blood monocyte cell (PBMC) culture
PBMCs were isolated from heparinized venous blood taken
from a voluntary donor using ficoll-histopaque density gradient as
described previously [55]. The cell viability was checked by trypan
blue dye exclusion method and was found to be 90%.
Approximately 0.5 million cells/well were seeded in 24 well plate
in RPMI 1640 media supplemented with 10%FBS and 2 mM
glutamine. Cells were treated with rHP986 protein as described
above.
Cytokine assay
Amount of IL-8 and TNF-a secreted in the culture medium was
determined using commercially available optEIA ELISA Kit (BD
Biosciences, USA) as per manufacturer’s instruction. The cytokine
Figure 6. Schematic representation of major signaling pathways initiated following the binding of HP986 with TNFR1. The proposed
interactions possibly activate downstream signaling cascades leading to macrophage apoptosis and induction of proinflammatory cytokines. TRADD:
TNFR1 associated death domain, FADD: Fas- associated death domain, TRAF2: TNFR- associated factor 2, RIP: Receptor interacting protein.
doi:10.1371/journal.pone.0022530.g006
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levels were calculated using the recombinant standard provided
within the kit.
Cell extract preparation and Electrophoretic mobility
shift assay
Cytoplasmic and nuclear extracts were prepared and transloca-
tion of NF-kB complex was determined by electrophoretic mobility
shift assay (EMSA) as described earlier [56]. Unlabeled NF-kB
consensus probe was used as specific competitor. For supershift
assay 5-10 mg of rabbit polyclonal anti p65, p50, c-Rel antibodies
(Santacruz Biotechnology, USA) were used. After electrophoresis
the gel was dried and analyzed by autoradiography.
Immunobloting
Immunobloting was performed as described previously [57].
Different antibodies such as those against p65, p50, c-Rel, TNFR1,
TLR4 and TLR2 (Santacruz Biotechnology, USA) were used.
Immunoreactive proteins were detected using enhanced chemilumi-
nescence kit according to manufacturer’s instructions (Amersham
Inc., USA). b-Actin was used to confirm equal loading of the samples.
rHP986 binding assay by flow cytometry
Binding of rHP986 with cell surface receptors such as TLR4,
TLR2 (Imgenex, USA) and TNFR1(Santacruz Biotechnology,
USA) was analyzed using specific antibodies by flow cytometry.
FITC conjugated mouse IgG1 antibody (Santacruz Biotechnology,
USA) was used as isotype-matched control Antibody. At least
10,000 cells were scanned per sample.
Immunoprecipitation
0.1 mg/ml of cell extract was incubated with rHP986 overnight
at 4uC and the immune complexes were trapped using Talon resin
(Clontech, USA) or protein A/G agarose beads (Santa Cruz,
USA). Immune complexes were separated on 10% SDS-PAGE
and the immunoblot was developed using enhanced chemilumi-
nescence kit (Amersham Inc, USA). Recombinant ICD from H.
pylori and LPS were used as controls.
Kinetic analysis of interaction using Surface Plasmon
Resonance (SPR)
Binding kinetics of rHP986 with soluble humanTNFR1 (hu
TNFR1) were analyzed using BIAcoreH 3000 SPR system (GE
Healthcare Ltd.). Human TNFR1/Fc (Sigma, USA) was immobi-
lized by an amine-coupling method over a research grade CM5
sensor chip (BiAcore, Uppsala, Sweden) up to a resonance unit of
150. A reference surface was used as a blank to correct instrumental
and buffer effects prior to protein injection. During the association
phase, the purified rHP986 had been serially diluted in running buffer
(PBS, BiAcore, Uppsala, Sweden) at 100 nM, 400 nM, 800 nM, and
1200 nM and were allowed to pass individually over the immobilized
TNFR1 at a flow rate of 30 ml/min for 3 minutes. During the
dissociation phase, PBS solution was applied to the sensor chip at a
flow rate of 30 ml/min for 4 minutes. The sensor surface was
regenerated between each binding reactions by two washes of 30 s
each with 5 M NaOH as evaluated by baseline response. The data
was analyzed with BIAEVALUATION 4.1 software (GEHealthcare
Ltd.) using simple 1:1 Langmuir interaction model.
Assay of CD95 for rHP986 mediated apoptosis
Expression of CD95 was analyzed by flow cytometry using
FITC conjugated anti-Fas monoclonal antibody (CD95, BD) [58].
FITC conjugated mouse IgG1 antibody (Santa Cruz) was used as
isotype-matched control antibody. Cells stimulated in the presence
of neutralizing antibody to TNFR1 (50 mg/ml) were used to check
the involvement of TNFR1 in the regulation of Fas expression.
Analysis of CD95 expression by Immunocytochemistry
Cells were sedimented on glass slide and fixed in 1%
paraformaldehyde at 4uC for 30 minutes. For antigen staining
cells were incubated with rabbit polyclonal anti-Fas antibody
(1:300, Santa Cruz, USA) for 1–2 hours at 37uC. Unbound
antibody was washed off with PBS and the cells were further
incubated with Alexafluor [44] conjugated anti-rabbit IgG (1:200,
Molecular probes, USA) for 30 minutes at room temperature [10].
Enhanced Fas expression was analyzed by fluorescence microsco-
py (Ziess epifluorescence microscope).
Analysis of apoptosis induction by rHP986
Apoptosis assays were performed using acridine orange/
ethidium bromide staining [11] and annexinV kit method (BD
pharmingen, USA). For acridine orange and ethidium bromide
assay, approximately 100 cells were counted in three randomly
selected fields and the rate of apoptosis was expressed as mean
percentage of total 300 cells counted. For annexinV, percentages
of apoptotic cells were expressed as total % of annexinV+ and PI+
cells after subtracting background fluorescence [46]. Cells treated
with rHP986 in presence and absence of neutralizing antibodies to
TNF-a and TNFR1 were used to determine the role of rHP986 in
the induction of apoptosis. Oleandrin, a known potent inducer of
apoptosis [34] was used as a positive control. Lysate of the cells not
exposed to rHP986 served as negative control.
Statistical Analysis
Results were expressed as means 6 the standard error (SE).
Induction of cytokine levels and the rate of apoptosis were
compared using a two-tailed Student’s t test and considered
significant if the P values were ,0.05. P values were calculated
using the online Graph Pad scientific calculator (http://www.
graphpad.com_quickcalcs_ttest1.cfm).
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